RESUMEN
Pediatric patients with congenital heart defects (CHD) often present with heart failure from increased load on the right ventricle (RV) due to both surgical methods to treat CHD and the disease itself. Patients with RV failure often require transplantation, which is limited due to lack of donor availability and rejection. Previous studies investigating the development and in vitro assessment of a bioprinted cardiac patch composed of cardiac extracellular matrix (cECM) and human c-kit + progenitor cells (hCPCs) showed that the construct has promise in treating cardiac dysfunction. The current study investigates in vivo cardiac outcomes of patch implantation in a rat model of RV failure. Patch parameters including cECM-inclusion and hCPC-inclusion are investigated. Assessments include hCPC retention, RV function, and tissue remodeling (vascularization, hypertrophy, and fibrosis). Animal model evaluation shows that both cell-free and neonatal hCPC-laden cECM-gelatin methacrylate (GelMA) patches improve RV function and tissue remodeling compared to other patch groups and controls. Inclusion of cECM is the most influential parameter driving therapeutic improvements, with or without cell inclusion. This study paves the way for clinical translation in treating pediatric heart failure using bioprinted GelMA-cECM and hCPC-GelMA-cECM patches.
Asunto(s)
Insuficiencia Cardíaca , Células Madre , Animales , Niño , Matriz Extracelular , Gelatina , Corazón , Humanos , RatasRESUMEN
Patients with aortic heart valve disease are limited to valve replacements that lack the ability to grow and remodel. This presents a major challenge for pediatric patients who require a valve capable of somatic growth and at a smaller size. A patient-specific heart valve capable of growth and remodeling while maintaining proper valve function would address this major issue. Here, we recreate the native valve leaflet structure composed of poly-ε-caprolactone (PCL) and cell-laden gelatin-methacrylate/poly (ethylene glycol) diacrylate (GelMA/PEGDA) hydrogels using 3D printing and molding, and then evaluate the ability of the multilayered scaffold to produce collagen matrix under physiological shear stress conditions. We also characterized the valve hemodynamics under aortic physiological flow conditions. The valve's fibrosa layer was replicated by 3D printing PCL in a circumferential direction similar to collagen alignment in the native leaflet, and GelMA/PEGDA sustained and promoted cell viability in the spongiosa/ventricularis layers. We found that collagen type I production can be increased in the multilayered scaffold when it is exposed to pulsatile shear stress conditions over static conditions. When the PCL component was mounted onto a valve ring and tested under physiological aortic valve conditions, the hemodynamics were comparable to commercially available valves. Our results demonstrate that a structurally representative valve leaflet can be generated using 3D printing and that the PCL layer of the leaflet can sustain proper valve function under physiological aortic valve conditions.
Asunto(s)
Válvula Aórtica , Enfermedades de las Válvulas Cardíacas , Niño , Colágeno , Colágeno Tipo I , Hemodinámica , HumanosRESUMEN
Decellularized extracellular matrix (dECM) is a promising biomaterial for repairing cardiovascular tissue, as dECM most effectively captures the complex array of proteins, glycosaminoglycans, proteoglycans, and many other matrix components that are found in native tissue, providing ideal cues for regeneration and repair of damaged myocardium. dECM can be used in a variety of forms, such as solid scaffolds that maintain native matrix structure, or as soluble materials that can form injectable hydrogels for tissue repair. dECM has found recent success in many regeneration and repair therapies, such as for musculoskeletal, neural, and liver tissues. This review focuses on dECM in the context of cardiovascular applications, with variations in tissue and species sourcing, and specifically discusses advances in solid and soluble dECM development, in vitro studies, in vivo implementation, and clinical translation.
Asunto(s)
Materiales Biocompatibles/química , Sistema Cardiovascular/efectos de los fármacos , Matriz Extracelular/efectos de los fármacos , Regeneración/efectos de los fármacos , Andamios del Tejido/química , Animales , Humanos , Miocardio/patología , Ingeniería de Tejidos/métodosRESUMEN
Congenital heart defects are present in 8 of 1000 newborns and palliative surgical therapy has increased survival. Despite improved outcomes, many children develop reduced cardiac function and heart failure requiring transplantation. Human cardiac progenitor cell (hCPC) therapy has potential to repair the pediatric myocardium through release of reparative factors, but therapy suffers from limited hCPC retention and functionality. Decellularized cardiac extracellular matrix hydrogel (cECM) improves heart function in animals, and human trials are ongoing. In the present study, a 3D-bioprinted patch containing cECM for delivery of pediatric hCPCs is developed. Cardiac patches are printed with bioinks composed of cECM, hCPCs, and gelatin methacrylate (GelMA). GelMA-cECM bioinks print uniformly with a homogeneous distribution of cECM and hCPCs. hCPCs maintain >75% viability and incorporation of cECM within patches results in a 30-fold increase in cardiogenic gene expression of hCPCs compared to hCPCs grown in pure GelMA patches. Conditioned media from GelMA-cECM patches show increased angiogenic potential (>2-fold) over GelMA alone, as seen by improved endothelial cell tube formation. Finally, patches are retained on rat hearts and show vascularization over 14 d in vivo. This work shows the successful bioprinting and implementation of cECM-hCPC patches for potential use in repairing damaged myocardium.
Asunto(s)
Bioimpresión , Matriz Extracelular/metabolismo , Células Madre/citología , Animales , Células Cultivadas , Módulo de Elasticidad , Gelatina/química , Cardiopatías/patología , Cardiopatías/terapia , Cardiopatías/veterinaria , Humanos , Hidrogeles/química , Miocardio/citología , Miocitos Cardíacos/citología , Impresión Tridimensional , Ratas , Ratas Sprague-Dawley , Trasplante de Células Madre , Células Madre/metabolismo , Ingeniería de Tejidos , Andamios del TejidoRESUMEN
The rotational diffusion of polyethylene glycol coated magnetic nanoparticles in serum albumin solutions was investigated in a range spanning 0mgmL-1 to 200mgmL-1. Rotational diffusivities were determined from dynamic magnetic susceptibility measurements, which provide a non-optical means to probe rotation of nanoparticles in small volume samples. Experimental rotational diffusivities were compared to those estimated using the Stokes-Einstein relation and macroscopic measurements of the viscosity of the protein solutions. Excellent agreement was found between experimental measurements and theoretical predictions for serum albumin solutions buffered at physiological pH and for serum albumin solutions at acidic pH prepared using simple acids at physiological ionic strengths. For serum albumin solutions prepared using citrate buffer at acidic pH, we observed a discrepancy between the experimental rotational diffusivity and that predicted from the Stokes-Einstein relation. In contrast, when the pH was adjusted with a simple acid and salt at physiological ionic strength we observed agreement between the experimental rotational diffusivity and that predicted from the Stokes-Einstein relation. Because of the role of citrate ions in causing protein aggregation, we believe these observations suggest that dynamic magnetic susceptibility measurement of the rotational diffusivity of the nanoparticles is sensitive to gelation/crosslinking of proteins.